Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced clinical confidence for radiologists. ABUS can play an important role in early diagnosis of small, node negative, invasive cancers. Hear from Georgia Giakoumis Spear, M.D., from NorthShore University HealthSystem in the Chicagoland Area of Illinois as she speaks with Lucas Delaney, general manager for ABUS at GE Healthcare. As an early adopter of ABUS, she discusses the clinical need and her results with ABUS. She also provides her impressions of the newly introduced Invenia ABUS 2.0, and demonstrates a case utilizing the coronal view.

See GE Healthcare Introduces Invenia ABUS 2.0.

An interview with A. M. Niser Syed, M.D., medical director, radiation oncology and endocurietherapy, MemorialCare Cancer Institute, Long Beach, Calif. At the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting, he presented a study of 1,200 patients using a single session of intra-operative radiation therapy (IORT) using the Xoft X-ray emitting brachytherapy system. 

ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., about the hospital's use of new technology and innovative practices. Read more about the clinic the article "High-Risk Clinic Arms Patients Against Breast Cancer."

See more content from ITN's visit to Northwestern Medicine Central DuPage Hospital.

Related Breast Imaging Content: 

VIDEO: The Impact of Breast Density Technology and Legislation

High-Risk Clinic Arms Patients Against Breast Cancer

Greater Evidence, Payment Expansion Driving Tomosynthesis Adoption

Technology to Watch in Breast Imaging

VIDEO: Developments in Breast Density Legislation and Screening Guidelines

The Transition to 3-D Breast Imaging

Fujifilm details its latest innovations in women's health including its ASPIRE Cristalle mammography system with digital breast tomosynthesis software option and its Synapse 5 PACS and VNA, enabling secure, easy-to-manage storage and access to the complete patient imaging record throughout the healthcare enterprise.

Nancy M. Cappello, Ph.D., executive director and founder, Are You Dense Inc. and Are You Dense Advocacy. Read the article “The Evolution of Breast Imaging Technology.” Watch the VIDEO “Implementing Advanced Breast Imaging Technology.” 

Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologist, Elizabeth Wende Breast Care, explains recent advances in mammography and dense breast imaging at the 2017 Radiological Society of North America (RSNA) meeting. Read the article “The Evolution of Breast Imaging Technology.” Watch the VIDEO “Implementing Advanced Breast Imaging Technology.” 

Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how a personalized breast screening program can improve cancer detection for women with dense breasts at the 2017 AHRA annual meeting in Anaheim. Read an article by Cappello “Fake News: Having Dense Breast Tissue is No Big Deal,”  or the article "Raising the Bar For Cancer Detection in Dense Breast Tissue."

ITN and DAIC Editor Dave Fornell takes a tour of some of the most innovative new technologies being displayed on the expo floor at the Radiological Society of North America (RSNA) 2016 meeting. For key take away trends at RSNA, watch the video "Key Trends, New Technology at RSNA 2016."

Interview with Gerald Kolb, JD, president of The Breast Group in Bend, Ore. Kolb spoke at the 2016 AHRA meeting in Nashville about the challenges of multimodality breast screening, the need for more personalized screening programs and the impact of recent screening recommendations. Read about the lastest advances in breast imaging.

Kristie Bobolis, M.D., president elect and current chair of 2016 Planning Committee for the National Consortium of Breast Centers, discusses the role of genetic testing, how it is evolving, and how a physician best assess the high-risk patient.

Barbara Rabinowitz, Ph.D., MSW, RN, founder of the National Consortium of Breast Centers, talks with ITN editorial director Melinda Taschetta-Millane during NCoBC's 26th annual conference, and addresses the very important topic of survivorship.

This year's keynote speaker, Nancy M. Cappello, Ph.D., founder and director of Are You Dense and Are You Dense Advocacy, Inc., expands on her keynote presentation "Why I Talk to Strangers About My Breasts."

Ralph Highnam, chief executive officer, reviews product highlights at RSNA 2015, including the recent FDA 510(k) clearance of Volpara Density Software.

ITN Editor Dave Fornell shares his choices for some of the most innovative new technology on the show floor at the 2015 AHRA meeting in Las Vegas.

During the American Association of Physicists in Medicine (AAPM) 57th annual meeting in Anaheim, Calif., graduate student researcher at the University of California/Davis Andrew M. Hernandez discussed screening and dose distribution for women with dense breasts, and its implications for mammography.

Dense breast tissue can mask the appearance of tumors and limit the performance of mammography. When used as an adjunct to mammography, Invenia ABUS from GE Healthcare has been shown to improve invasive breast cancer detection by 55% over mammography alone.

Barbara Rabinowitz, Ph.D., MSW, RN, founder of the National Consortium of Breast Centers, talks with ITN editorial director Melinda Taschetta-Millane during NCoBC's 25th anniversary conference, and addresses the very important topic of survivorship.

Jennifer Gass, M.D., FACS, incoming president of the National Consortium of Breast Centers, discusses the impact of breast surgery on a woman's sense of sexuality, and her future goals during her presidency of NCBC.

Volpara now offers products to track breast density in mammography, X-ray radiation dose and analytical data. The company now integrates with tomosynthesis 3-D mammo systems. The technology has installations in 31 countries.